Surgery & Perioperative Care
ABP-700 is an intravenous sedative-hypnotic agent being developed for the induction of general anesthesia and/or procedural sedation in patients undergoing diagnostic or therapeutic procedures. ABP-700 is a positive allosteric modulator of the γ-aminobutyric acid type A (GABAA) receptor, a fast-acting inhibitory neurotransmitter receptor in the central nervous system (CNS).
For information on ongoing clinical trials click here.
The above investigational agent is not approved for commercial use in any market; the safety and efficacy has not been evaluated by any regulatory authority for the uses described.
Global Medical Information
The Global Health Science Center (GHSC) Medical Professionals are available to answer your medical information requests, or receive adverse event reports, other safety related information, and product complaints.
Please click below to contact the Global Health Science Center.
Alternatively, adverse events may be reported to the FDA MedWatch Reporting System by phone at 1 800 FDA 1088 (1 800 332 1088) or by mail using Form FDA 3500 at www.fda.gov/medwatch